PowerVR AX3125 is a cost-sensitive solution for low-power applications – i.e. where power draw is a key issue. It can run at up to 0.6 TOPS in IoT devices, entry-level smart cameras, embedded ... The ...

DexCom's growth is slowing with 2024 marking the slowest growth year in a decade and 2025 expected to follow suit with ~14% ...

Investors with significant funds have taken a bearish position in DexCom (NASDAQ:DXCM), a development that retail traders should be aware of. This was brought to our attention today through our ...

DexCom has done a decent job managing its cost base over the last five years. The company has produced an average operating margin of 14.4%, higher than the broader healthcare sector. Looking at ...

underscoring operational and cost challenges faced by the company. The quarter featured significant strategic moves, including the submission of the Dexcom G7 15-day CGM system to the FDA.

My name is Abby, and I will be your conference operator today. At this time, I would like to welcome everyone to the Dexcom Inc. fourth quarter 2024 earnings release conference call. All lines ...

SAN DIEGO - DexCom, Inc. (NASDAQ:DXCM), a prominent player in glucose biosensing technology with a market capitalization of $30.4 billion, announced on Monday the addition of Renée Galá to its ...

DexCom said that on Tuesday it received a warning letter from the U.S. FDA following inspections at its facilities in San Diego, Calif., and Mesa, Ariz. related to concerns about manufacturing ...